TY - JOUR
T1 - Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo
AU - Sun, Xiaorong
AU - Xing, Ligang
AU - Deng, Xuelong
AU - Hsiao, Hung Tsung
AU - Manami, Akiko
AU - Koutcher, Jason A.
AU - Clifton Ling, C.
AU - Li, Gloria C.
N1 - Funding Information:
This work was supported in part by Grants from the National Institutes of Health ( PO1 CA115675 , RO1 CA56909 , and R33 CA109772 and NSFC 81001004). This publication also acknowledges NCI Grant P30-CA 08748 , which provides partial support for the Research Animal Resource Center, Animal Imaging, Molecular Cytology and Flow Cytometry core facilities at MSKCC in conducting this investigation.
PY - 2012/10
Y1 - 2012/10
N2 - Purpose: To investigate whether hypoxia targeted bifunctional suicide gene expression-cytosine deaminase (CD) and uracil phosphoribosyltransferase (UPRT) with 5-FC treatments can enhance radiotherapy. Materials and methods: Stable transfectants of R3327-AT cells were established which express a triple-fusion-gene: CD, UPRT and monomoric DsRed (mDsRed) controlled by a hypoxia inducible promoter. Hypoxia-induced expression/function of CDUPRTmDsRed was verified by western blot, flow cytometry, fluorescent microscopy, and cytotoxicity assay of 5-FU and 5-FC. Tumor-bearing mice were treated with 5-FC and local radiation. Tumor volume was monitored and compared with those treated with 5-FC or radiation alone. In addition, the CDUPRTmDsRed distribution in hypoxic regions of tumor sections was visualized with fluorescent microscopy. Results: Hypoxic induction of CDUPRTmDsRed protein correlated with increased sensitivity to 5-FC and 5-FU. Significant radiosensitization effects were detected after 5-FC treatments under hypoxic conditions. In the tumor xenografts, the distribution of CDUPRTmDsRed expression visualized with fluorescence microscopy was co-localized with the hypoxia marker pimonidazole positive staining cells. Furthermore, administration of 5-FC to mice in combination with local irradiation resulted in significant tumor regression, as in comparison with 5-FC or radiation treatments alone. Conclusions: Our data suggest that the hypoxia-inducible CDUPRT/5-FC gene therapy strategy has the ability to specifically target hypoxic cancer cells and significantly improve the tumor control in combination with radiotherapy.
AB - Purpose: To investigate whether hypoxia targeted bifunctional suicide gene expression-cytosine deaminase (CD) and uracil phosphoribosyltransferase (UPRT) with 5-FC treatments can enhance radiotherapy. Materials and methods: Stable transfectants of R3327-AT cells were established which express a triple-fusion-gene: CD, UPRT and monomoric DsRed (mDsRed) controlled by a hypoxia inducible promoter. Hypoxia-induced expression/function of CDUPRTmDsRed was verified by western blot, flow cytometry, fluorescent microscopy, and cytotoxicity assay of 5-FU and 5-FC. Tumor-bearing mice were treated with 5-FC and local radiation. Tumor volume was monitored and compared with those treated with 5-FC or radiation alone. In addition, the CDUPRTmDsRed distribution in hypoxic regions of tumor sections was visualized with fluorescent microscopy. Results: Hypoxic induction of CDUPRTmDsRed protein correlated with increased sensitivity to 5-FC and 5-FU. Significant radiosensitization effects were detected after 5-FC treatments under hypoxic conditions. In the tumor xenografts, the distribution of CDUPRTmDsRed expression visualized with fluorescence microscopy was co-localized with the hypoxia marker pimonidazole positive staining cells. Furthermore, administration of 5-FC to mice in combination with local irradiation resulted in significant tumor regression, as in comparison with 5-FC or radiation treatments alone. Conclusions: Our data suggest that the hypoxia-inducible CDUPRT/5-FC gene therapy strategy has the ability to specifically target hypoxic cancer cells and significantly improve the tumor control in combination with radiotherapy.
UR - http://www.scopus.com/inward/record.url?scp=84868374271&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868374271&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2012.07.011
DO - 10.1016/j.radonc.2012.07.011
M3 - Article
C2 - 22938726
AN - SCOPUS:84868374271
SN - 0167-8140
VL - 105
SP - 57
EP - 63
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 1
ER -